GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telomir Pharmaceuticals Inc (NAS:TELO) » Definitions » Inventories, Inventories Adjustments

Telomir Pharmaceuticals (Telomir Pharmaceuticals) Inventories, Inventories Adjustments : $0.00 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Telomir Pharmaceuticals Inventories, Inventories Adjustments?

Telomir Pharmaceuticals's Inventories, Inventories Adjustments for the quarter that ended in Mar. 2024 was $0.00 Mil.


Telomir Pharmaceuticals Inventories, Inventories Adjustments Historical Data

The historical data trend for Telomir Pharmaceuticals's Inventories, Inventories Adjustments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telomir Pharmaceuticals Inventories, Inventories Adjustments Chart

Telomir Pharmaceuticals Annual Data
Trend Dec21 Dec22 Dec23
Inventories, Inventories Adjustments
- - -

Telomir Pharmaceuticals Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Inventories Adjustments Get a 7-Day Free Trial Premium Member Only - - - - -

Telomir Pharmaceuticals Inventories, Inventories Adjustments Calculation

Inventories, Inventories Adjustments represents certain charges made in the current period in inventory resulting from breakage, spoilage, employee theft and shoplifting, etc.


Telomir Pharmaceuticals (Telomir Pharmaceuticals) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.

Telomir Pharmaceuticals (Telomir Pharmaceuticals) Headlines